Perioperative use of a beta blocker in coronary artery bypass grafting

Asian Cardiovascular and Thoracic Annals

Volumn 21, Issue 3, 2013, Pages 265-269

  Ogawa, Shinji ^a   Okawa, Yasuhide ^a   Goto, Yoshihiro ^a   Aoki, Masakazu ^a   Baba, Hiroshi ^a  

^a Toyohashi Heart Center Toyohashi   (Japan)

Author keywords

adrenergic beta antagonists; atrial fibrillation; coronary artery bypass; Landiolol supplementary concept ; perioperative care

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; INOTROPIC AGENT; LANDIOLOL; TROPONIN I;

ADULT; ARTICLE; BRADYCARDIA; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TACHYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; LANDIOLOL [SUPPLEMENTARY CONCEPT]; PERIOPERATIVE CARE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; INCIDENCE; INFLAMMATION; INFUSIONS, PARENTERAL; JAPAN; MALE; MIDDLE AGED; MORPHOLINES; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; UREA;

EID: 84879488194     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492312451166     Document Type: Article

References (12)

1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001 ; 135: 1061-1073
2. Srinivasan AK, Shackcloth MJ, Grayson AD, Fabri BM. Preoperative beta-blocker therapy in coronary artery bypass surgery: a propensity score analysis of outcomes. Interact Cardiovasc Thorac Surg. 2003 ; 2: 495-500
3. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004 ; 291: 1720-1729
4. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000 ; 101: 1403-1408
5. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg. 2005 ; 79: 1530-1535
6. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006 ; 114: 1455-1461
7. Imren Y, Benson AA, Zor H, Tasoglu I, Ereren E, Sinci V, et al. Preoperative beta-blocker use reduces atrial fibrillation in off-pump coronary bypass surgery. ANZ J Surg. 2007 ; 77: 429-432
8. Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011 ; 141: 1478-1487
9. Raja SG, Behranwala AA, Dunning J. Does off-pump coronary artery surgery reduce the incidence of postoperative atrial fibrillation?. Interact Cardiovasc Thorac Surg. 2004 ; 3: 647-652
10. Halonen J, Hakala T, Auvinen T, Karjalainen J, Turpeinen A, Uusaro A, et al. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation. 2006 ; 114(Suppl I): 1-4
11. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg. 2005 ; 79: 1530-1535
12. Torre-Amine G. Immune activation in chronic heart failure [Review]. Am J Cardiol. 2005 ; 95 (11A). 3C - 8C